Knight Therapeutics (04K.MU) Q3 2026 Earnings

6AugConfirmed
Q2 2026
Next
0.01
0.03
0.06
0.08

Details

Expected EPS
0.00882234924
Actual EPS
N/A
Surprise EPS
-0.01
Surprise Percent
+100%

Description

Knight Therapeutics (04K.MU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts